Analysts’ Viewpoint
Prevalence of chronic diseases, including cancer, cardiovascular disorders, and autoimmune conditions, has risen significantly, creating an urgent need for effective treatments. Cell therapies have emerged as a potential solution by offering targeted and personalized approaches, particularly for patients unresponsive to conventional therapies. Surge in patient population and increase in demand for more efficient treatments these diseases are driving the global cell therapy technologies market. Supportive regulatory frameworks have fueled the development and commercialization of cell therapies. Furthermore, increase in awareness and acceptance of cell therapies among healthcare professionals and patients is propelling global cell therapy technologies market demand.
Advancements in cell therapies for the treatment of various chronic diseases offer lucrative opportunities to market players. Companies are focusing on increasing the efficacy and safety of cell therapies to provide improved disease management outcomes for patients.
The cell therapy technologies market refers to the field of medical treatment that involves the use of living cells to restore or improve the functioning of damaged or diseased tissues and organs. It is a rapidly evolving and promising area of research & development within the broader field of regenerative medicine.
Cell therapy technologies offer the potential to revolutionize the treatment of various diseases, including cancer, cardiovascular disorders, neurological conditions, and autoimmune diseases. Product development in the cell therapy technologies market is characterized by ongoing research and clinical trials to evaluate the safety and efficacy of different cell-based therapies.
Scientists and companies are exploring various approaches, including cell-based immunotherapies, gene therapies, tissue engineering, and ex vivo cell expansion techniques. Significant progress has been made in the development of CAR-T cell therapies for cancer treatment, where immune cells are genetically engineered to recognize and target cancer cells.
Researchers are investigating the potential of stem cell therapies for conditions such as spinal cord injuries, heart diseases, and neurodegenerative disorders. Ongoing research and product development efforts aim to further expand the range of cell therapies available and improve their safety, efficacy, and accessibility.
Chronic conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, and autoimmune disorders pose significant challenges to the healthcare industry. Conventional treatment approaches often provide limited success in managing or curing these diseases.
Cell therapy, with its potential to repair, regenerate, or replace damaged tissues or organs, offers a promising alternative. The ability of cell therapies to address the underlying cause of diseases and promote long-term healing has garnered significant attention.
Over the years, there have been notable developments in cell therapy technologies to combat chronic and degenerative diseases. For instance, advancements in stem cell research have led to the identification and isolation of various types of stem cells with different therapeutic potential. Researchers are exploring the use of mesenchymal stem cells, induced pluripotent stem cells, and hematopoietic stem cells in developing innovative cell-based therapies.
Thus, rise in prevalence of chronic and degenerative diseases is likely to bolster global cell therapy technologies market size during the forecast period.
Cell therapy, which involves usage of living cells to treat or cure diseases, has emerged as a promising field in regenerative medicine. However, the success of cell therapies depends on the availability of advanced technologies that enable efficient cell manufacturing, characterization, and delivery.
Companies in the cell therapy sector are investing significantly in research & development of proprietary technologies that enhance the efficacy, safety, and scalability of cell therapies. These technologies encompass a wide range of areas, including cell culture systems, cell isolation & expansion methods, cryopreservation techniques, and cell characterization tools.
Development of advanced cell culture systems is a key area of focus. Companies are working on the design and optimization of culture media, growth factors, and bioreactors that provide an ideal environment for cell expansion and maintenance of cell viability and functionality. These proprietary culture systems are aimed at improving cell yields, reducing production costs, and enabling the scalable manufacturing of cell therapies.
Supportive technologies related to cell isolation and purification are also receiving significant attention. Companies are developing novel techniques for isolating specific cell populations from complex mixtures, ensuring the purity and quality of cells used in therapies. These technologies enable the efficient isolation of therapeutic cell types and minimize the risk of contamination or unwanted cell populations.
Cryopreservation technologies are crucial for the long-term storage and transportation of cells. Companies are focused on developing improved cryopreservation methods that maintain cell viability, functionality, and genetic stability during freezing and thawing processes.
These advancements ensure the availability of viable cells at the point of therapy administration, even when there are logistical challenges associated with cell transportation and storage.
Therefore, development of proprietary & supportive technologies is projected to augment global cell therapy technologies market growth.
In terms of cell type, the autologous segment accounted for the largest global cell therapy technologies market share in 2022. The segment is expected to grow at a higher CAGR during the forecast period.
Autologous cell therapy involves using a patient's own cells for treatment. These therapies offer the advantage of personalized medicine, as they are tailor-made to each patient's specific needs. This eliminates the risk of immune rejection or adverse reactions, as the cells used are derived from the patient's own body.
Based on application, the cancer segment is projected to dominate the global cell therapy technologies industry during the forecast period. Cancer is a global health challenge affecting millions of people, and there is a significant unmet need for effective treatments.
Cell therapies, such as chimeric antigen receptor (CAR) T-cell therapy, have shown promising results in treating certain types of cancers, particularly hematological malignancies such as leukemia and lymphoma. These therapies involve modifying a patient's own immune cells to recognize and attack cancer cells, offering a potentially curative approach.
As per cell therapy technologies market trends, North America is projected to account for the major share of market during the forecast period. The region has a robust and well-established healthcare infrastructure, which includes advanced research facilities, leading academic institutions, and a strong regulatory framework. This supportive ecosystem fosters innovation, accelerates clinical trials, and facilitates the commercialization of cell therapy products.
North America exhibits high prevalence of chronic diseases, including cancer, cardiovascular disorders, and autoimmune conditions, which are key indications targeted by cell therapies. Large patient population and rise in demand for effective treatments contribute to market growth.
Europe has witnessed growing focus on fostering innovation and advancing cell therapy research. The region has strong presence of renowned academic institutions, research organizations, and biotechnology companies, which contribute to the development of cutting-edge cell therapies.
In terms of regulatory advancements, the European Medicines Agency (EMA) has established a regulatory framework specifically tailored for advanced therapy medicinal products (ATMPs), which include cell therapies. This framework, along with the EMA's Priority Medicines (PRIME) scheme, accelerates the assessment and approval processes for promising therapies, promoting their timely availability to patients.
Asia Pacific has a large patient population, particularly in countries such as China and India, which face a high burden of chronic diseases. This provides a substantial market opportunity for cell therapy technologies. Additionally, countries in Asia Pacific have been investing in research & development, fostering collaborations between academia, industry, and government organizations.
The global cell therapy technologies market is fragmented, with the presence of a number of players. Agilent Technologies, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., Miltenyi Biotech, GE Healthcare, Beckman Coulter, Inc. (Danaher), Sartorius AG, Lonza Group, Terumo Corporation, and Curate Biosciences are the prominent players in the market.
These players have adopted strategies such as mergers & acquisitions, strategic collaborations, and new product launches to expand presence and increase market share.
The cell therapy technologies market report profiles the top players based on various factors including a company overview, financial summary, strategies, product portfolio, segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Size in 2022 |
US$ 14.9 Bn |
|
Forecast Value in 2031 |
More than US$ 36.0 Bn |
|
CAGR - 2022-2031 |
10.5% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
The global industry was valued at US$ 14.9 Bn in 2022
It is projected to reach more than US$ 36.0 Bn by 2031
It is anticipated to expand at a CAGR of 10.5% from 2023 to 2031
North America is expected to account for the largest share from 2023 to 2031
Agilent Technologies, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., Miltenyi Biotech, GE Healthcare, Beckman Coulter, Inc. (Danaher), Sartorius AG, Lonza Group, Terumo Corporation, and Curate Biosciences are the prominent players in the market
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Therapy Technologies Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Therapy Technologies Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Overview of Cell Therapy Product Manufacturing Technologies
5.3. List of Instruments and Consumables Used For Each of the Technologies
5.4. Key Mergers & Acquisitions
5.5. Top 3 Players Operating in the Market Space
6. Global Cell Therapy Technologies Market Analysis and Forecast, by Cell Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Cell Type, 2017-2031
6.3.1. Allogeneic
6.3.1.1. Blood Cells
6.3.1.2. Others
6.3.2. Autologous
6.3.2.1. Human Embryonic Stem Cells
6.3.2.2. Hematopoietic Stem Cells
6.3.2.3. Mesenchymal Stem Cells
6.3.2.4. Others
6.4. Market Attractiveness Analysis, by Cell Type
7. Global Cell Therapy Technologies Market Analysis and Forecast, by Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Product, 2017-2031
7.3.1. Tissue Digestion
7.3.1.1. Instrumentation
7.3.1.2. Consumables & Reagents
7.3.2. Cell Selection/ Cell Isolation
7.3.2.1. Instrumentation
7.3.2.2. Consumables & Reagents
7.3.3. Cell Viability Testing
7.3.3.1. Instrumentation
7.3.3.2. Consumables & Reagents
7.3.4. Cell Transduction / Transfection
7.3.4.1. Instrumentation
7.3.4.2. Consumables & Reagents
7.3.5. Cell Expansion
7.3.5.1. Instrumentation
7.3.5.2. Consumables & Reagents
7.3.6. Quality Control Testing
7.3.6.1. Instrumentation
7.3.6.2. Consumables & Reagents
7.4. Market Attractiveness Analysis, by Product
8. Global Cell Therapy Technologies Market Analysis and Forecast, by Technology/Method
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technology/Method, 2017-2031
8.3.1. Tissue Digestion
8.3.2. Cell Selection/Cell Isolation
8.3.2.1. Immunomagnetic Cell separation (IMS)
8.3.2.2. Fluorescence-activated Cell Sorting(FACS)
8.3.2.3. Density Gradient Centrifugation
8.3.2.4. Microfluidic Cell Separation (MCS)
8.3.2.5. Others
8.3.3. Cell Viability Testing
8.3.3.1. Tetrazolium Reduction Assay
8.3.3.2. Protease Viability Marker Assay
8.3.3.3. ATP Assay
8.3.3.4. Real-Time Assay
8.3.3.5. Others
8.3.4. Cell Transduction/Transfection
8.3.4.1. Cationic-lipid Mediated Transfection
8.3.4.2. Calcium Phosphate Transfection
8.3.4.3. Viral Transfection
8.3.4.4. Electroporation
8.3.4.5. Others
8.3.5. Cell Expansion
8.3.5.1. 3D Cell Culture
8.3.5.2. Roller Bottle Culture
8.3.5.3. Cell Culture Scale-up Systems
8.3.5.4. Spinner Flask Culture
8.3.5.5. Others
8.3.6. Quality Control Testing
8.3.6.1. Endotoxin
8.3.6.2. Mycoplasma
8.3.6.3. Others
8.4. Market Attractiveness Analysis, by Technology/Method
9. Global Cell Therapy Technologies Market Analysis and Forecast, by Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Application, 2017-2031
9.3.1. Cancer
9.3.2. Autoimmune Diseases
9.3.3. Cardiovascular Disorders
9.3.4. Orthopedic Disorders
9.3.5. Others
9.4. Market Attractiveness Analysis, by Application
10. Global Cell Therapy Technologies Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Cell Therapy Technologies Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Cell Type, 2017-2031
11.2.1. Allogeneic
11.2.1.1. Blood Cells
11.2.1.2. Others
11.2.2. Autologous
11.2.2.1. Human Embryonic Stem Cells
11.2.2.2. Hematopoietic Stem Cells
11.2.2.3. Mesenchymal Stem Cells
11.2.2.4. Others
11.3. Market Value Forecast, by Product, 2017-2031
11.3.1. Tissue Digestion
11.3.1.1. Instrumentation
11.3.1.2. Consumables & Reagents
11.3.2. Cell Selection/ Cell Isolation
11.3.2.1. Instrumentation
11.3.2.2. Consumables & Reagents
11.3.3. Cell Viability Testing
11.3.3.1. Instrumentation
11.3.3.2. Consumables & Reagents
11.3.4. Cell Transduction / Transfection
11.3.4.1. Instrumentation
11.3.4.2. Consumables & Reagents
11.3.5. Cell Expansion
11.3.5.1. Instrumentation
11.3.5.2. Consumables & Reagents
11.3.6. Quality Control Testing
11.3.6.1. Instrumentation
11.3.6.2. Consumables & Reagents
11.4. Market Value Forecast, by Technology/Method, 2017-2031
11.4.1. Tissue Digestion
11.4.2. Cell Selection/Cell Isolation
11.4.2.1. Immunomagnetic Cell separation (IMS)
11.4.2.2. Fluorescence-activated Cell Sorting(FACS)
11.4.2.3. Density Gradient Centrifugation
11.4.2.4. Microfluidic Cell Separation (MCS)
11.4.2.5. Others
11.4.3. Cell Viability Testing
11.4.3.1. Tetrazolium Reduction Assay
11.4.3.2. Protease Viability Marker Assay
11.4.3.3. ATP Assay
11.4.3.4. Real-Time Assay
11.4.3.5. Others
11.4.4. Cell Transduction/Transfection
11.4.4.1. Cationic-lipid Mediated Transfection
11.4.4.2. Calcium Phosphate Transfection
11.4.4.3. Viral Transfection
11.4.4.4. Electroporation
11.4.4.5. Others
11.4.5. Cell Expansion
11.4.5.1. 3D Cell Culture
11.4.5.2. Roller Bottle Culture
11.4.5.3. Cell Culture Scale-up Systems
11.4.5.4. Spinner Flask Culture
11.4.5.5. Others
11.4.6. Quality Control Testing
11.4.6.1. Endotoxin
11.4.6.2. Mycoplasma
11.4.6.3. Others
11.5. Market Value Forecast, by Application, 2017-2031
11.5.1. Cancer
11.5.2. Autoimmune Diseases
11.5.3. Cardiovascular Disorders
11.5.4. Orthopedic Disorders
11.5.5. Others
11.6. Market Value Forecast, by Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Cell Type
11.7.2. By Product
11.7.3. By Technology/Method
11.7.4. By Application
11.7.5. By Country
12. Europe Cell Therapy Technologies Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Cell Type, 2017-2031
12.2.1. Allogeneic
12.2.1.1. Blood Cells
12.2.1.2. Others
12.2.2. Autologous
12.2.2.1. Human Embryonic Stem Cells
12.2.2.2. Hematopoietic Stem Cells
12.2.2.3. Mesenchymal Stem Cells
12.2.2.4. Others
12.3. Market Value Forecast, by Product, 2017-2031
12.3.1. Tissue Digestion
12.3.1.1. Instrumentation
12.3.1.2. Consumables & Reagents
12.3.2. Cell Selection/ Cell Isolation
12.3.2.1. Instrumentation
12.3.2.2. Consumables & Reagents
12.3.3. Cell Viability Testing
12.3.3.1. Instrumentation
12.3.3.2. Consumables & Reagents
12.3.4. Cell Transduction / Transfection
12.3.4.1. Instrumentation
12.3.4.2. Consumables & Reagents
12.3.5. Cell Expansion
12.3.5.1. Instrumentation
12.3.5.2. Consumables & Reagents
12.3.6. Quality Control Testing
12.3.6.1. Instrumentation
12.3.6.2. Consumables & Reagents
12.4. Market Value Forecast, by Technology/Method, 2017-2031
12.4.1. Cell Selection/Cell Isolation
12.4.1.1. Immunomagnetic Cell separation (IMS)
12.4.1.2. Fluorescence-activated Cell Sorting(FACS)
12.4.1.3. Density Gradient Centrifugation
12.4.1.4. Microfluidic Cell Separation (MCS)
12.4.1.5. Others
12.4.2. Cell Viability Testing
12.4.2.1. Tetrazolium Reduction Assay
12.4.2.2. Protease Viability Marker Assay
12.4.2.3. ATP Assay
12.4.2.4. Real-Time Assay
12.4.2.5. Others
12.4.3. Cell Transduction/Transfection
12.4.3.1. Cationic-lipid Mediated Transfection
12.4.3.2. Calcium Phosphate Transfection
12.4.3.3. Viral Transfection
12.4.3.4. Electroporation
12.4.3.5. Others
12.4.4. Cell Expansion
12.4.4.1. 3D Cell Culture
12.4.4.2. Roller Bottle Culture
12.4.4.3. Cell Culture Scale-up Systems
12.4.4.4. Spinner Flask Culture
12.4.4.5. Others
12.4.5. Quality Control Testing
12.4.5.1. Endotoxin
12.4.5.2. Mycoplasma
12.4.5.3. Others
12.5. Market Value Forecast, by Application, 2017-2031
12.5.1. Cancer
12.5.2. Autoimmune Diseases
12.5.3. Cardiovascular Disorders
12.5.4. Orthopedic Disorders
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Cell Type
12.7.2. By Product
12.7.3. By Technology/Method
12.7.4. By Application
12.7.5. By Country/Sub-region
13. Asia Pacific Cell Therapy Technologies Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Cell Type, 2017-2031
13.2.1. Allogeneic
13.2.1.1. Blood Cells
13.2.1.2. Others
13.2.2. Autologous
13.2.2.1. Human Embryonic Stem Cells
13.2.2.2. Hematopoietic Stem Cells
13.2.2.3. Mesenchymal Stem Cells
13.2.2.4. Others
13.3. Market Value Forecast, by Product, 2017-2031
13.3.1. Tissue Digestion
13.3.1.1. Instrumentation
13.3.1.2. Consumables & Reagents
13.3.2. Cell Selection/ Cell Isolation
13.3.2.1. Instrumentation
13.3.2.2. Consumables & Reagents
13.3.3. Cell Viability Testing
13.3.3.1. Instrumentation
13.3.3.2. Consumables & Reagents
13.3.4. Cell Transduction / Transfection
13.3.4.1. Instrumentation
13.3.4.2. Consumables & Reagents
13.3.5. Cell Expansion
13.3.5.1. Instrumentation
13.3.5.2. Consumables & Reagents
13.3.6. Quality Control Testing
13.3.6.1. Instrumentation
13.3.6.2. Consumables & Reagents
13.4. Market Value Forecast, by Technology/Method, 2017-2031
13.4.1. Tissue Digestion
13.4.2. Cell Selection/Cell Isolation
13.4.2.1. Immunomagnetic Cell separation (IMS)
13.4.2.2. Fluorescence-activated Cell Sorting(FACS)
13.4.2.3. Density Gradient Centrifugation
13.4.2.4. Microfluidic Cell Separation (MCS)
13.4.2.5. Others
13.4.3. Cell Viability Testing
13.4.3.1. Tetrazolium Reduction Assay
13.4.3.2. Protease Viability Marker Assay
13.4.3.3. ATP Assay
13.4.3.4. Real-Time Assay
13.4.3.5. Others
13.4.4. Cell Transduction/Transfection
13.4.4.1. Cationic-lipid Mediated Transfection
13.4.4.2. Calcium Phosphate Transfection
13.4.4.3. Viral Transfection
13.4.4.4. Electroporation
13.4.4.5. Others
13.4.5. Cell Expansion
13.4.5.1. 3D Cell Culture
13.4.5.2. Roller Bottle Culture
13.4.5.3. Cell Culture Scale-up Systems
13.4.5.4. Spinner Flask Culture
13.4.5.5. Others
13.4.6. Quality Control Testing
13.4.6.1. Endotoxin
13.4.6.2. Mycoplasma
13.4.6.3. Others
13.5. Market Value Forecast, by Application, 2017-2031
13.5.1. Cancer
13.5.2. Autoimmune Diseases
13.5.3. Cardiovascular Disorders
13.5.4. Orthopedic Disorders
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Cell Type
13.7.2. By Product
13.7.3. By Technology/Method
13.7.4. By Application
13.7.5. By Country/Sub-region
14. Latin America Cell Therapy Technologies Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Cell Type, 2017-2031
14.2.1. Allogeneic
14.2.1.1. Blood Cells
14.2.1.2. Others
14.2.2. Autologous
14.2.2.1. Human Embryonic Stem Cells
14.2.2.2. Hematopoietic Stem Cells
14.2.2.3. Mesenchymal Stem Cells
14.2.2.4. Others
14.3. Market Value Forecast, by Product, 2017-2031
14.3.1. Tissue Digestion
14.3.1.1. Instrumentation
14.3.1.2. Consumables & Reagents
14.3.2. Cell Selection/ Cell Isolation
14.3.2.1. Instrumentation
14.3.2.2. Consumables & Reagents
14.3.3. Cell Viability Testing
14.3.3.1. Instrumentation
14.3.3.2. Consumables & Reagents
14.3.4. Cell Transduction / Transfection
14.3.4.1. Instrumentation
14.3.4.2. Consumables & Reagents
14.3.5. Cell Expansion
14.3.5.1. Instrumentation
14.3.5.2. Consumables & Reagents
14.3.6. Quality Control Testing
14.3.6.1. Instrumentation
14.3.6.2. Consumables & Reagents
14.4. Market Value Forecast, by Technology/Method, 2017-2031
14.4.1. Tissue Digestion
14.4.2. Cell Selection/Cell Isolation
14.4.2.1. Immunomagnetic Cell separation (IMS)
14.4.2.2. Fluorescence-activated Cell Sorting(FACS)
14.4.2.3. Density Gradient Centrifugation
14.4.2.4. Microfluidic Cell Separation (MCS)
14.4.2.5. Others
14.4.3. Cell Viability Testing
14.4.3.1. Tetrazolium Reduction Assay
14.4.3.2. Protease Viability Marker Assay
14.4.3.3. ATP Assay
14.4.3.4. Real-Time Assay
14.4.3.5. Others
14.4.4. Cell Transduction/Transfection
14.4.4.1. Cationic-lipid Mediated Transfection
14.4.4.2. Calcium Phosphate Transfection
14.4.4.3. Viral Transfection
14.4.4.4. Electroporation
14.4.4.5. Others
14.4.5. Cell Expansion
14.4.5.1. 3D Cell Culture
14.4.5.2. Roller Bottle Culture
14.4.5.3. Cell Culture Scale-up Systems
14.4.5.4. Spinner Flask Culture
14.4.5.5. Others
14.4.6. Quality Control Testing
14.4.6.1. Endotoxin
14.4.6.2. Mycoplasma
14.4.6.3. Others
14.5. Market Value Forecast, by Application, 2017-2031
14.5.1. Cancer
14.5.2. Autoimmune Diseases
14.5.3. Cardiovascular Disorders
14.5.4. Orthopedic Disorders
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Cell Type
14.7.2. By Product
14.7.3. By Technology/Method
14.7.4. By Application
14.7.5. By Country/Sub-region
15. Middle East & Africa Cell Therapy Technologies Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Cell Type, 2017-2031
15.2.1. Allogeneic
15.2.1.1. Blood Cells
15.2.1.2. Others
15.2.2. Autologous
15.2.2.1. Human Embryonic Stem Cells
15.2.2.2. Hematopoietic Stem Cells
15.2.2.3. Mesenchymal Stem Cells
15.2.2.4. Others
15.3. Market Value Forecast, by Product, 2017-2031
15.3.1. Tissue Digestion
15.3.1.1. Instrumentation
15.3.1.2. Consumables & Reagents
15.3.2. Cell Selection/ Cell Isolation
15.3.2.1. Instrumentation
15.3.2.2. Consumables & Reagents
15.3.3. Cell Viability Testing
15.3.3.1. Instrumentation
15.3.3.2. Consumables & Reagents
15.3.4. Cell Transduction / Transfection
15.3.4.1. Instrumentation
15.3.4.2. Consumables & Reagents
15.3.5. Cell Expansion
15.3.5.1. Instrumentation
15.3.5.2. Consumables & Reagents
15.3.6. Quality Control Testing
15.3.6.1. Instrumentation
15.3.6.2. Consumables & Reagents
15.4. Market Value Forecast, by Technology/Method, 2017-2031
15.4.1. Tissue Digestion
15.4.2. Cell Selection/Cell Isolation
15.4.2.1. Immunomagnetic Cell separation (IMS)
15.4.2.2. Fluorescence-activated Cell Sorting(FACS)
15.4.2.3. Density Gradient Centrifugation
15.4.2.4. Microfluidic Cell Separation (MCS)
15.4.2.5. Others
15.4.3. Cell Viability Testing
15.4.3.1. Tetrazolium Reduction Assay
15.4.3.2. Protease Viability Marker Assay
15.4.3.3. ATP Assay
15.4.3.4. Real-Time Assay
15.4.3.5. Others
15.4.4. Cell Transduction/Transfection
15.4.4.1. Cationic-lipid Mediated Transfection
15.4.4.2. Calcium Phosphate Transfection
15.4.4.3. Viral Transfection
15.4.4.4. Electroporation
15.4.4.5. Others
15.4.5. Cell Expansion
15.4.5.1. 3D Cell Culture
15.4.5.2. Roller Bottle Culture
15.4.5.3. Cell Culture Scale-up Systems
15.4.5.4. Spinner Flask Culture
15.4.5.5. Others
15.4.6. Quality Control Testing
15.4.6.1. Endotoxin
15.4.6.2. Mycoplasma
15.4.6.3. Others
15.5. Market Value Forecast, by Application, 2017-2031
15.5.1. Cancer
15.5.2. Autoimmune Diseases
15.5.3. Cardiovascular Disorders
15.5.4. Orthopedic Disorders
15.5.5. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Cell Type
15.7.2. By Product
15.7.3. By Technology/Method
15.7.4. By Application
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Share Analysis, by Company, 2022
16.2. Company Profiles
16.2.1. Agilent Technologies
16.2.1.1. Company Overview
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Business Strategies
16.2.1.5. Recent Developments
16.2.2. Merck KGaA
16.2.2.1. Company Overview
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Business Strategies
16.2.2.5. Recent Developments
16.2.3. Thermo Fisher Scientific, Inc.
16.2.3.1. Company Overview
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Business Strategies
16.2.3.5. Recent Developments
16.2.4. Miltenyi Biotech
16.2.4.1. Company Overview
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Business Strategies
16.2.4.5. Recent Developments
16.2.5. GE Healthcare (General Electric Company)
16.2.5.1. Company Overview
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Business Strategies
16.2.5.5. Recent Developments
16.2.6. Beckman Coulter, Inc. (Danaher)
16.2.6.1. Company Overview
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Business Strategies
16.2.6.5. Recent Developments
16.2.7. Sartorius AG
16.2.7.1. Company Overview
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Business Strategies
16.2.7.5. Recent Developments
16.2.8. Lonza Group
16.2.8.1. Company Overview
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Business Strategies
16.2.8.5. Recent Developments
16.2.9. Terumo Corporation
16.2.9.1. Company Overview
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Business Strategies
16.2.9.5. Recent Developments
16.2.10. Curate Biosciences
16.2.10.1. Company Overview
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Business Strategies
16.2.10.5. Recent Developments
List of Tables
Table 01: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031
Table 02: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031
Table 03: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031
Table 04: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 05: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 06: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 07: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 08: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 09: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 10: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 04: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031
Table 11: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 12: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 13: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 14: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 15: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 16: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 17: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 18: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 19: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 20: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031
Table 21: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031
Table 22: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031
Table 23: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 24: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 25: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 26: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 27: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 28: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 29: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 23: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method 2017-2031
Table 30: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 31: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 32: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 33: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 34: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 35: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 36: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 37: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 38: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031
Table 39: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031
Table 40: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031
Table 41: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 42: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 43: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation by Product, 2017-2031
Table 44: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 45: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection by Product, 2017-2031
Table 46: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 47: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 48: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031
Table 49: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 50: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 51: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 52: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 53: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 54: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 55: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 56: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 57: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031
Table 58: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031
Table 59: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031
Table 60: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 61: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 62: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031
Table 63: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 64: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection by Product, 2017-2031
Table 65: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 66: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 67: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031
Table 68: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 69: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 70: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 71: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 72: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 73: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 74: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 75: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 76: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031
Table 77: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031
Table 78: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031
Table 79: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 80: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 81: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031
Table 82: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 83: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction /Transfection, 2017-2031
Table 84: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 85: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 86: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method, 2017-2031
Table 87: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 88: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 89: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 90: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 91: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 92: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 93: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 94: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 95: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Type, 2017-2031
Table 96: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Allogeneic, 2017-2031
Table 97: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Autologous, 2017-2031
Table 98: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 99: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 100: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/ Cell Isolation by Product, 2017-2031
Table 101: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 102: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction /Transfection, 2017-2031
Table 103: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 104: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 105: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Technology/Method 2017-2031
Table 106: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Tissue Digestion, 2017-2031
Table 107: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Selection/Cell Isolation, 2017-2031
Table 108: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Viability Testing, 2017-2031
Table 109: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Transduction/Transfection, 2017-2031
Table 110: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Cell Expansion, 2017-2031
Table 111: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Quality Control Testing, 2017-2031
Table 112: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
List of Figures
Figure 01: Global Cell Therapy Technologies Market Snapshot
Figure 02: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast, 2017-2031
Figure 03: Global Cell Therapy Technologies Market Value Share, by Technology/Method, 2022
Figure 04: Global Cell Therapy Technologies Market Value Share, by Product, 2022
Figure 05: Global Cell Therapy Technologies Market Value Share, by Cell Type, 2022
Figure 06: Global Cell Therapy Technologies Market Value Share, by Application, 2022
Figure 07: Global Cell Therapy Technologies Market Value Share, by Region, 2022
Figure 08: Global Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031
Figure 09: Global Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031
Figure 10: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Allogeneic, 2017-2031
Figure 11: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Autologous, 2017-2031
Figure 12: Global Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031
Figure 13: Global Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031
Figure 14: Global Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031
Figure 15: Global Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031
Figure 16: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tissue Digestion, 2017-2031
Figure 17: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Selection/Cell Isolation, 2017-2031
Figure 18: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Viability Testing, 2017-2031
Figure 19: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Transduction/Transfection, 2017-2031
Figure 20: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Expansion, 2017-2031
Figure 21: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), By Quality Control Testing , 2017-2031
Figure 22: Global Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031
Figure 23: Global Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031
Figure 24: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tissue Digestion, 2017-2031
Figure 25: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Selection/Cell Isolation, 2017-2031
Figure 26: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Viability Testing, 2017-2031
Figure 27: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Transduction/Transfection, 2017-2031
Figure 28: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cell Expansion, 2017-2031
Figure 29: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Quality Control Testing, 2017-2031
Figure 30: Global Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031
Figure 31: Global Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031
Figure 32: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cancer, 2017-2031
Figure 33: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Autoimmune Diseases, 2017-2031
Figure 34: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiovascular Disorders, 2017-2031
Figure 35: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Orthopedic Disorders, 2017-2031
Figure 36: Global Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2017-2031
Figure 37: Global Cell Therapy Technologies Market Value Share, by Region, 2022 and 2031
Figure 38: Global Cell Therapy Technologies Market Attractiveness Analysis, by Region, 2023-2031
Figure 39: North America Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 40: North America Cell Therapy Technologies Market Value Share (%) Analysis, by Country, 2022 and 2031
Figure 41: North America Cell Therapy Technologies Market Attractiveness Analysis, by Country, 2023-2031
Figure 42: North America Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031
Figure 43: North America Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031
Figure 44: North America Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031
Figure 45: North America Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031
Figure 46: North America Cell Therapy Technologies Market Value Share Analysis, by Technology/ Method, 2022 and 2031
Figure 47: North America Cell Therapy Technologies Market Attractiveness Analysis, by Technology/ Method, 2023-2031
Figure 48: North America Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031
Figure 49: North America Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031
Figure 50: Europe Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 51: Europe Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 53: Europe Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031
Figure 54: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031
Figure 55: Europe Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031
Figure 56: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031
Figure 57: Europe Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031
Figure 58: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031
Figure 59: Europe Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031
Figure 60: Europe Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031
Figure 61: Asia Pacific Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 62: Asia Pacific Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 and 2031
Figure 63: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 64: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031
Figure 65: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031
Figure 66: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031
Figure 67: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Product,, 2023-2031
Figure 68: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031
Figure 69: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031
Figure 70: Asia Pacific Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031
Figure 71: Asia Pacific Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031
Figure 72: Latin America Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 73: Latin America Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 and 2031
Figure 74: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 75: Latin America Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031
Figure 76: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031
Figure 77: Latin America Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031
Figure 78: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Product,, 2023-2031
Figure 79: Latin America Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031
Figure 80: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031
Figure 81: Latin America Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031
Figure 82: Latin America Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031
Figure 83: Middle East & Africa Cell Therapy Technologies Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 84: Middle East & Africa Cell Therapy Technologies Market Value Share (%) Analysis, by Country/Sub-region, 2022 & 2031
Figure 85: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 86: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Cell Type, 2022 and 2031
Figure 87: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Cell Type, 2023-2031
Figure 88: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Product, 2022 and 2031
Figure 89: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Product, 2023-2031
Figure 90: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Technology/Method, 2022 and 2031
Figure 91: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Technology/Method, 2023-2031
Figure 92: Middle East & Africa Cell Therapy Technologies Market Value Share Analysis, by Application, 2022 and 2031
Figure 93: Middle East & Africa Cell Therapy Technologies Market Attractiveness Analysis, by Application, 2023-2031
Figure 94: Company Share Analysis
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cell Therapy Technologies Market
